Drugs / [68Ga]BED003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07702292 | Jun 2026 → Feb 2028 expected | colorectal cancer, gastric cancer, invasive lobular breast carcinoma, malignant epithelial tumor of ovary +1 | Blue Earth Diagnostics | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [68Ga]BED003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07702292 ↗ |